| Literature DB >> 24853742 |
Rick K Huang1, Ulrich Baxa2, Gudrun Aldrian3, Abdullah B Ahmed3, Joseph S Wall4, Naoko Mizuno5, Oleg Antzutkin6, Alasdair C Steven7, Andrey V Kajava8.
Abstract
The established correlation between neurodegenerative disorders and intracerebral deposition of polyglutamine aggregates motivates attempts to better understand their fibrillar structure. We designed polyglutamines with a few lysines inserted to overcome the hindrance of extreme insolubility and two D-lysines to limit the lengths of β-strands. One is 33 amino acids long (PolyQKd-33) and the other has one fewer glutamine (PolyQKd-32). Both form well-dispersed fibrils suitable for analysis by electron microscopy. Electron diffraction confirmed cross-β structures in both fibrils. Remarkably, the deletion of just one glutamine residue from the middle of the peptide leads to substantially different amyloid structures. PolyQKd-32 fibrils are consistently 10-20% wider than PolyQKd-33, as measured by negative staining, cryo-electron microscopy, and scanning transmission electron microscopy. Scanning transmission electron microscopy analysis revealed that the PolyQKd-32 fibrils have 50% higher mass-per-length than PolyQKd-33. This distinction can be explained by a superpleated β-structure model for PolyQKd-33 and a model with two β-solenoid protofibrils for PolyQKd-32. These data provide evidence for β-arch-containing structures in polyglutamine fibrils and open future possibilities for structure-based drug design.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24853742 PMCID: PMC4052364 DOI: 10.1016/j.bpj.2014.03.047
Source DB: PubMed Journal: Biophys J ISSN: 0006-3495 Impact factor: 4.033